First Horizon Corporation’s DexCom DXCM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.5K Sell
988
-227
-19% -$15.1K ﹤0.01% 623
2026
Q1
$76.3K Sell
1,215
-313
-20% -$21.8K ﹤0.01% 542
2025
Q4
$101K Sell
1,528
-161
-10% -$10.4K ﹤0.01% 507
2025
Q3
$114K Buy
+1,689
New +$134K 0.01% 463
2021
Q2
$10K Buy
96
+4
+4% +$384 ﹤0.01% 684
2021
Q1
$8K Buy
92
+60
+188% +$5.63K ﹤0.01% 730
2020
Q4
$2K Sell
32
-40
-56% -$3.57K ﹤0.01% 907
2020
Q3
$7K Buy
+72
New +$7.52K ﹤0.01% 690

Other funds holding DXCM

First Horizon Corporation's DXCM Position: Q2 2026 in Review

First Horizon Corporation reduced its DexCom (DXCM) stake by 19% in Q2 2026, selling an estimated $15.1K and leaving 988 shares worth $66.5K. The position accounts for ﹤0.01% of the portfolio, ranked #623.

First Horizon Corporation first reported a position in DXCM in Q3 2020 and has held it in 8 quarters since. The position peaked at $114K in Q3 2025. 378 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

  • First Horizon Corporation held 988 shares of DexCom worth $66.5K as of Q2 2026.
  • First Horizon Corporation sold 227 DexCom shares in Q2 2026, an estimated $15.1K.
  • DexCom made up ﹤0.01% of First Horizon Corporation's portfolio in Q2 2026, its #623 holding.
  • First Horizon Corporation first reported a position in DexCom in Q3 2020 and has held it in 8 quarters since.
  • First Horizon Corporation's DexCom position peaked at $114K in Q3 2025.
  • 378 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.